MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination.
The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.
The KATMAP model, developed by researchers in the Department of Biology, can predict alternative cell splicing, which allows cells to create endless diversity from the same sets of genetic blueprints.
A leading researcher in protein folding biochemistry and next-generation protein engineering techniques will advance chemistry research and education.
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
Professor Caroline Uhler discusses her work at the Schmidt Center, thorny problems in math, and the ongoing quest to understand some of the most complex interactions in biology.
A commitment from longtime supporters Patricia and James Poitras ’63 initiates multidisciplinary efforts to understand and treat complex psychiatric disorders.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
Combining powerful imaging, perturbational screening, and machine learning, researchers uncover new human host factors that alter Ebola’s ability to infect.